Nektar Therapeutics (NKTR) PT Raised to $63 at Evercore ISI; 'Highlights from 4Q earnings call'
Tweet
Share
E-mail
Get Alerts NKTR Hot Sheet
Price: $65.70 +7.74%
Rating Summary:
20 Buy, 7 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Rating Summary:
20 Buy, 7 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
Evercore ISI raised its price target on Nektar Therapeutics (NASDAQ: NKTR) to $63.00 (from $31.00) while maintaining a In Line rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx (FDX) PT Lowered to $424 at Bernstein SocGen Group
- Regenxbio Inc. (RGNX) PT Raised to $32 at Baird
- SiteOne Landscape Supply (SITE) PT Lowered to $153 at Stifel
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
